Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 07-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,900 | 3,600 | -452,900 | -446,500 | -467,200 |
| Depreciation Amortization | 32,300 | 15,600 | 476,700 | 424,300 | 53,900 |
| Income taxes - deferred | -300 | -300 | -5,800 | -4,700 | -4,400 |
| Accounts receivable | -18,800 | 13,300 | 41,700 | 45,800 | 29,500 |
| Accounts payable and accrued liabilities | -5,400 | -9,400 | -17,800 | -22,400 | -6,300 |
| Other Working Capital | -24,500 | -5,900 | -3,100 | -18,000 | -20,900 |
| Other Operating Activity | 42,500 | -2,600 | 41,100 | 74,200 | 484,300 |
| Operating Cash Flow | $16,900 | $14,300 | $79,900 | $52,700 | $68,900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13,500 | -6,700 | -26,700 | -20,900 | -23,400 |
| Net Acquisitions | 11,200 | 12,500 | -200 | -200 | -2,700 |
| Purchase Of Investment | -122,500 | N/A | -52,700 | -52,600 | -53,200 |
| Sale Of Investment | 6,200 | 2,000 | 200 | N/A | 11,900 |
| Other Investing Activity | 14,200 | 2,300 | -10,800 | -7,800 | -6,900 |
| Investing Cash Flow | $-104,400 | $10,100 | $-90,200 | $-81,500 | $-74,300 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -200 | N/A | -2,600 | N/A |
| Debt Repayment | -500 | N/A | -2,700 | N/A | -2,000 |
| Common Stock Repurchased | N/A | N/A | -94,100 | -94,100 | -101,200 |
| Other Financing Activity | -1,500 | -1,500 | 0 | 0 | 0 |
| Financing Cash Flow | $-2,000 | $-1,700 | $-96,800 | $-96,700 | $-103,200 |
| Exchange Rate Effect | 200 | 300 | 11,200 | 5,700 | -5,000 |
| Beginning Cash Position | 535,500 | 535,500 | 631,400 | 631,400 | 601,900 |
| End Cash Position | 446,200 | 558,500 | 535,500 | 511,600 | 488,300 |
| Net Cash Flow | $-89,300 | $23,000 | $-95,900 | $-119,800 | $-113,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 16,900 | 14,300 | 79,900 | 52,700 | 68,900 |
| Capital Expenditure | -14,100 | -6,700 | -32,000 | -25,600 | -28,000 |
| Free Cash Flow | 2,800 | 7,600 | 47,900 | 27,100 | 40,900 |